The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.00
Bid: 10.50
Ask: 11.50
Change: -0.25 (-2.22%)
Spread: 1.00 (9.524%)
Open: 11.25
High: 11.05
Low: 10.50
Prev. Close: 11.25
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Belluscura Ltd Launches Wire CaddyT In USA

1 Mar 2017 07:00

RNS Number : 1208Y
Tekcapital plc
01 March 2017
 

1 March 2017

Tekcapital plc

("Tekcapital" or the "Company")

 

BELLUSCURA LTD LAUNCHES WIRE CADDY™ IN USA

Tekcapital plc (AIM: TEK), an international provider of technology and intellectual property services, announces that Belluscura Ltd ("Belluscura") has launched its Wire Caddyproduct in the United States.

The Wire Caddy is an innovative wire management system that provides lubrication and organization during multi-wire, multi-exchange operating room cases, such as cardiology interventions, uterine fibroid embolizations and tibial angioplasties.

The Wire Caddy was designed by interventional radiologist Dr Shaun Samuels to address unique challenges in complex surgical procedures, especially those involving multi-wire and multi-exchange cases. Its unobtrusive positioning allows quick access to lubricated guidewires during surgical procedures in interventional radiology, catheterization laboratory, vascular suite and other operating room operations. Belluscura's Wire Caddy is particularly useful for single operators, interventional radiology trainees, fellows and residents.

Belluscura's Chief Executive Officer Bob Rauker said:

"Wire Caddy is an excellent component in our product portfolio, which offers premium and affordable solutions to meet the needs of the patient and healthcare providers".

About Belluscura:

Belluscura Limited is a global medical device company founded in Oxford, England. Its mission is to make healthcare more affordable for patients and their providers by providing proprietary medical devices across a wide variety of treatment and diagnostic disciplines. Belluscura's products were originally developed by leading medical device companies or research centres, and with its unique business model it is able to offer these devices at affordable prices. To learn more about Belluscura please visit www.belluscura.com.

Tekcapital owns approximately 65% of the share capital of Belluscura.

 

 

For further information, please contact:

 

Tekcapital Plc

 

Clifford M. Gross, Ph.D.

info@tekcapital.com

 

Allenby Capital Limited (Nominated Adviser & Joint Broker)

 

+44 (0) 20 3328 5656

Jeremy Porter / Alex Brearley

 

 

 

Dowgate Capital Stockbrokers (Joint Broker)

+44 (0) 1293 517744

David Poutney / James Serjeant

 

 

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Paul Cornelius / Helen Cresswell / Sam Allen

tekcapital@walbrookpr.com

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital helps clients profit from new, university-developed intellectual properties. With its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a turn-key service to make it easy for clients to find and acquire the IP, analytics and technology transfer professionals they need to create a competitive advantage. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

LEI: 213800GOJTOV19FIFZ85

  

http://www.rns-pdf.londonstockexchange.com/rns/1208Y_-2017-2-28.pdf

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABRGDDSBDBGRI
Date   Source Headline
22nd Jun 20231:27 pmRNSInnovative Eyewear US$ 4.7Million Public Offering
20th Jun 20237:00 amRNSInnovative Eyewear Licensing Agreement for Reebok
16th Jun 20237:00 amRNSSpace Florida Awards Grant to Guident and NOVELSAT
14th Jun 20237:00 amRNSGuident Secures New Patent
26th May 20237:00 amRNSFinal Results Year ended 31 December 2022
18th May 20237:00 amRNSMicroSalt Jack Stein appointed Brand Ambassador
17th May 20237:00 amRNSMicroSalt expands U.S. retail presence
4th May 20234:40 pmRNSNotification of Major Holdings
2nd May 20237:00 amRNSMicroSalt partners with large USA Retailer
27th Apr 20235:35 pmRNSNotification of Major Holdings
17th Apr 20237:00 amRNSPlacing to raise £2 Million (C.US $ 2.50M)
14th Apr 20238:00 amRNSInnovation Eyewear Hosts First Smart Eyewear Show
12th Apr 20238:00 amRNSPatent Filed for ChatGPT Enabled Smart Eyewear
11th Apr 20238:00 amRNSPortfolio Company Update Innovation Eyewear
22nd Mar 20237:00 amRNSMicroSalt Operational Update
17th Mar 20237:00 amRNSGuident Update
13th Mar 20237:00 amRNSH Mart Partners with MicroSalt
8th Mar 20234:39 pmRNSHolding(s) in Company
8th Mar 20233:59 pmRNSIssue of Equity and total voting rights
2nd Mar 20237:00 amRNSInnovative Eyewear Launches New Titanium Styles
27th Feb 20237:00 amRNSMicroSalt Expands Low Sodium Shakers Distribution
24th Feb 20237:00 amRNSNOVELSAT and Guident Partnership
21st Feb 20237:00 amRNSNotice of Investor Presentation
20th Feb 20237:00 amRNSPlacing to raise £2.25 Million(C.US$2.7M)
17th Feb 20237:00 amRNSGuident Portfolio Company Update
7th Feb 20237:00 amRNSLaunch of Lucyd Lyte 2.0 Smart Eyewear
6th Feb 20237:00 amRNSUS Salt forms Strategic Partnership with MicroSalt
6th Feb 20237:00 amRNSInnovative Eyewear New Features for Vyrb App
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSGiant Food agrees to carry MicroSalt Shakers
24th Jan 20233:19 pmRNSConversion of outstanding loan amount in MicroSalt
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
29th Dec 20222:00 pmRNSPrice Monitoring Extension
29th Dec 20227:00 amRNSInnovative Eyewear Global Licensing Agreement
28th Dec 20227:00 amRNSInnovative Eyewear Inc Provides Year end Review
21st Dec 20227:00 amRNSHannaford Brothers Partners with MicroSalt
20th Dec 20227:00 amRNSMicroSalt wins award
19th Dec 20227:00 amRNSNOMAD and Broker appointed for MicroSalt AIM IPO
8th Dec 20227:00 amRNSChange in Accounting Reference Date
15th Nov 20227:00 amRNSExercise of Stock Options and Total Voting Rights
14th Nov 20227:00 amRNSGuident to provide Autonomous Shuttle Services
31st Oct 20225:46 pmRNSHolding(s) in Company
31st Oct 20227:00 amRNSAppointment to the Board of MicroSalt
27th Oct 20227:00 amRNSGuident Update
25th Oct 20227:00 amRNSCFO Update
13th Oct 20227:00 amRNSMicroSalt Partnership
11th Oct 20227:00 amRNSInnovative Eyewear Executive Appointments
3rd Oct 20227:00 amRNSLucyd - Global Licensing Agreement Nautica Brand

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.